Kwmg, LLC Amgen Inc Transaction History

Kwmg, LLC

$986 Million
Q3 2024

A detailed history of Kwmg, LLC transactions in Amgen Inc stock. As of the latest transaction made, Kwmg, LLC holds 18,824 shares of AMGN stock, worth $4.96 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

18,824

Previous 18,962 0.73%

Holding current value

$4.96 Million

Previous $5.92 Million 2.38%

% of portfolio

0.62%

Previous 0.64%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 07, 2024	SELL	$309.38 - $337.38 $42,694 - $46,558	-138 Reduced 0.73%	18,824 $6.07 Million
Q2 2024 Jul 12, 2024	SELL	$262.75 - $319.31 $86,707 - $105,372	-330 Reduced 1.71%	18,962 $5.92 Million
Q1 2024 Apr 15, 2024	SELL	$268.87 - $324.56 $13,981 - $16,877	-52 Reduced 0.27%	19,292 $5.49 Million
Q4 2023 Jan 11, 2024	SELL	$255.7 - $288.46 $99,211 - $111,922	-388 Reduced 1.97%	19,344 $5.57 Million
Q3 2023 Oct 10, 2023	BUY	$218.65 - $271.46 $87,241 - $108,312	399 Added 2.06%	19,732 $5.3 Million
Q2 2023 Jul 10, 2023	BUY	$214.27 - $253.37 $280,479 - $331,661	1,309 Added 7.26%	19,333 $4.29 Million
Q1 2023 Apr 06, 2023	BUY	$225.79 - $275.2 $97,992 - $119,436	434 Added 2.47%	18,024 $4.36 Million
Q4 2022 Jan 10, 2023	SELL	$229.03 - $291.01 $64,815 - $82,355	-283 Reduced 1.58%	17,590 $0
Q3 2022 Oct 26, 2022	BUY	$224.46 - $253.15 $121,881 - $137,460	543 Added 3.13%	17,873 $4.03 Million
Q2 2022 Jul 12, 2022	BUY	$230.71 - $256.74 $131,966 - $146,855	572 Added 3.41%	17,330 $4.22 Million
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $379,337 - $419,646	1,730 Added 11.51%	16,758 $4.05 Million
Q4 2021 Jan 20, 2022	BUY	$198.88 - $227.6 $144,784 - $165,692	728 Added 5.09%	15,028 $3.38 Million
Q3 2021 Oct 07, 2021	BUY	$212.27 - $248.7 $192,953 - $226,068	909 Added 6.79%	14,300 $3.04 Million
Q2 2021 Jul 13, 2021	BUY	$233.58 - $259.14 $139,914 - $155,224	599 Added 4.68%	13,391 $3.27 Million
Q1 2021 Apr 12, 2021	BUY	$221.91 - $258.6 $141,356 - $164,728	637 Added 5.24%	12,792 $3.18 Million
Q4 2020 Jan 25, 2021	BUY	$216.38 - $257.67 $91,528 - $108,994	423 Added 3.61%	12,155 $2.8 Million
Q3 2020 Oct 07, 2020	BUY	$234.65 - $260.95 $74,149 - $82,460	316 Added 2.77%	11,732 $2.98 Million
Q2 2020 Jul 27, 2020	BUY	$197.81 - $242.74 $162,204 - $199,046	820 Added 7.74%	11,416 $2.69 Million
Q1 2020 Apr 13, 2020	BUY	$182.24 - $241.7 $7,654 - $10,151	42 Added 0.4%	10,596 $2.15 Million
Q4 2019 Jan 10, 2020	BUY	$189.21 - $243.2 $61,682 - $79,283	326 Added 3.19%	10,554 $2.54 Million
Q3 2019 Oct 22, 2019	BUY	$174.11 - $208.62 $1.78 Million - $2.13 Million	10,228 New	10,228 $1.98 Million
Q2 2019 Jul 10, 2019	SELL	$166.7 - $195.41 $97,852 - $114,705	-587 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$166.05 - $186.51 $97,471 - $109,481	587 New	587 $108,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kwmg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kwmg, LLC with notifications on news.

Account